Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis

Journal of NeuroVirology

Volumn 9, Issue 1, 2003, Pages 29-35

  Takenouchi, Norihiro ^a   Yamano, Yoshihisa ^b   Usuku, Koichiro ^b   Osame, Mitsuhiro ^b   Izumo, Shuji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

HTLV I associated myelopathy tropical spastic paraparesis (HAM TSP); Human T lymphotropic virus type I (HTLV I); Long term follow up; Proviral load; Quantitative PCR

Indexed keywords

ADULT; AGED; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; TIME PERCEPTION; VIRUS LOAD; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0344405657     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280390173418     Document Type: Review

References (36)

1. Al-Fahim A, Cabre P, et al (1999). Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased. Cell Immunol 198: 1-10.
2. Aye MM, Matsuoka E, et al (2000). Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol (Berl) 100: 245-252.
3. Furukawa Y, Yamashita M, et al (2000). Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 182: 1343-1349.
4. Gessain A, Barin F, et al (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2: 407-410.
5. Hara H, Morita M, et al (1994). Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Exp Med 180: 831-839.
6. Hashimoto K, Higuchi I, et al (1998). Quantitative in situ PCR assay of HTLV-1 infected cells in peripheral blood lymphocytes of patients with ATL, HAM/TSP and asymptomatic carriers. J Neurol Sci 159: 67-72.
7. Ijichi S, Eiraku N, et al (1989). Activated T lymphocytes in cerebrospinal fluid of patients with HTLV-I-associated myelopathy (HAM/TSP). J Neuroimmunol 25: 251-254.
8. Ijichi S, Izumo S, et al (1993). An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP. Med Hypotheses 41: 542-547.
9. Izumo S, Goto I, et al (1996). Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology 46: 1016-1021.
10. Izumo S, Umehara F, et al (1997). Neuropathology of HTLV-1-associated myelopathy (HAM/TSP). Leukemia 11: 82-84.
11. Jeffery KJ, Siddiqui AA, et al (2000). The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 165: 7278-7284.
12. Jeffery KJ, Usuku K, et al (1999). HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 96: 3848-3853.
13. Kambara C, Nakamura T, et al (1999). Vascular cell adhesion molecule-1-mediated matrix metalloproteinase-2 induction in peripheral blood T cells is up-regulated in patients with HTLV- I-associated myelopathy. J Neuroimmunol 99: 242-247.
14. Kubota R, Fujiyoshi T, et al (1993). Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J Neuroimmunol 42: 147-154.
15. Kubota R, Umehara F, et al (1994). HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J Neuroimmunol 53: 23-29.
16. Matsuo H, Nakamura T, et al (1989). Long-term-follow-up of immunomodulation in treatment of HTLV-I-associated myelopathy. Lancet 1: 790.
17. Matsuoka E, Takenouchi N, et al (1998). Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy/tropical spastic paraparesis: double staining of immunohistochemistry and polymerase chain reaction in situ hybridization. Acta Neuropathol (Berl) 96: 340-346.
18. Matsuoka E, Usuku K, et al (2000). CD44 splice variant involvement in the chronic inflammatory disease of the spinal cord: HAM/TSP. J Neuroimmunol 102: 1-7.
19. Mori M, Kinoshita K, et al (1988). Activated T-lymphocytes with polyclonal gammopathy in patients with human T-lymphotropic virus type I-associated myelopathy. Ann Neurol 24: 280-282.
20. Moritoyo T, Izumo S, et al (1999). Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/ tropical spastic paraparesis. J NeuroVirol 5: 241-248.
21. Moritoyo T, Reinhart TA, et al (1996). T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol 40: 84-90.
22. Nagai M, Usuku K, et al (1998). Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J NeuroVirol 4: 586-593.
23. Nagai M, Yamano Y, et al (2001). Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol 50: 807-812.
24. Nakagawa M, Izumo S, et al (1995). HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J NeuroVirol 1: 50-61.
25. Nakagawa M, Nakahara K, et al (1996). Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. J NeuroVirol 2: 345-355.
26. Nakamura T (2000). Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Med 32: 600-607.
27. Nakane S, Shirabe S, et al (2000). Comparative molecular analysis of HTLV-I proviral DNA in HTLV-I infected members of a family with a discordant HTLV-I-associated myelopathy in monozygotic twins. J NeuroVirol 6: 275-283.
28. Osame M, Igata A, et al (1990). HTLV-I-associated myelopathy (HAM). Treatment trials, retrospective survey, and clinical and laboratory findings. Hematol Rev 3: 271-284.
29. Osame M, Usuku K, et al (1986). HTLV-I-associated myelopathy, a new clinical entity [letter]. Lancet 1: 1031-1032.
30. Perelson AS, Neumann AU, et al (1996). HIV-1 dynamics in vivo: virion clearance rate, infected cell lifespan, and viral generation time. Science 271: 1582-1586.
31. Renjifo B, Chou K, et al (1996). Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome. J Acquir Immune Defic Syndr Hum Retrovirol 13: 146-153.
32. Romero IA, Prevost MC, et al (2000). Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system. J Virol 74: 6021-6030.
33. Takenouchi N, Matsuoka E, et al (1999). Molecular pathologic analysis of the tonsil in HTLV-I-infected individuals. J Acquir Immune Defic Syndr 22: 200-207.
34. Tateno M (1987). Rat lymphoid cell lines producing human T cell leukemia virus-I. Hokkaido Igaku Zasshi 62: 74-81.
35. Umehara F, Izumo S, et al (1996). Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol (Berl) 91: 343-350.
36. Yoshida M, Miyoshi I, et al (1982). Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79: 2031-2035.